SCHEMBL14715545

SCHEMBL14715545

Cc1ccc(C(=O)NCCc2ccccc2)cc1-c1ccc2nc(N)ncc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 7/20 0.58
KDR P35968 6/20 0.58
JAK3 P52333 6/20 0.58
MAPK14 Q16539 6/20 0.58
TEK Q02763 3/20 0.58
BRAF P15056 2/20 0.48
RIPK1 Q13546 1/20 0.48
RIPK3 Q9Y572 1/20 0.48
PDE2A O00408 1/20 0.47
PDE10A Q9Y233 1/20 0.47
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.47
POLB P06746 1/20 0.47
DDR2 Q16832 1/20 0.47
ROCK1 Q13464 1/20 0.47
TP53 P04637 1/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
NAMPT P43490 1/20 0.46
ABL1 P00519 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5502481 0.91 LCK (0.55) LCKKDRJAK3MAPK14TEK
SCHEMBL5497608 0.90 MAPK14 (0.60) LCKKDRJAK3MAPK14TEK
SCHEMBL5498233 0.85 MAPK14 (0.58) LCKKDRJAK3MAPK14TEK
SCHEMBL5497069 0.83 LCK (0.56) LCKKDRJAK3MAPK14TEK
SCHEMBL5489506 0.83 LCK (0.76) LCKKDRJAK3MAPK14TEK
SCHEMBL5496648 0.82 LCK (0.57) LCKKDRJAK3MAPK14TEK
SCHEMBL5498173 0.82 LCK (0.56) LCKKDRJAK3MAPK14TEK
SCHEMBL5496972 0.81 LCK (0.56) LCKKDRJAK3MAPK14TEK
SCHEMBL5489113 0.81 LCK (0.74) LCKKDRJAK3MAPK14TEK
SCHEMBL5488850 0.80 LCK (0.62) LCKKDRJAK3MAPK14TEK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836174-B2 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2019-10-02 EP disclosed
EP-1836174-B1 ARYL NITROGEN-CONTAINING BICYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS AMGEN INC (US) 2013-02-27 EP disclosed